Understanding Patient Adherence and Concerns with STatins and MedicatION Discussions With Physicians (ACTION): A survey on the patient perspective of dialogue with healthcare providers regarding statin therapy
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Background: Statins are first‐line for cholesterol lowering and prevention of atherosclerotic cardiovascular disease (ASCVD), but their use is complicated by side effects and potential for drug–drug interactions. Provider‐patient communication is the basis of the recommended shared decision‐making, but relatively little is known about this in the context of statin use. Methods: We surveyed 5014 US adults prescribed a statin for hypercholesterolemia to learn their perspectives on communication with their provider. Results: Ninety‐four percent reported currently taking a statin while 6% had stopped. Past users vs current users were more likely to be female, age < 65 years, and to have fewer cardiovascular disease–related comorbidities (hypertension, type 2 diabetes mellitus, and coronary heart disease, respectively). Although 93% of current statin users were taking ≥1 other prescription medications (median of 4), 76% were “not at all”/“not very concerned” about potential drug–drug interactions with their statin, and fewer than one‐quarter recalled mention of these from their provider. Ninety‐five percent of subjects said it was “extremely”/“somewhat” important that their healthcare provider take “an individualized approach to selecting the right statin,” but 73% and 76%, respectively, said their statin choice was made with little or no input from them. Only 25% were told that “some statins might be more likely than others to interact with other medications,” and only 18% (and only 20% of past users) were told that “their particular statin might interact with other medications.” Conclusion: Provider‐patient communication regarding statin therapy appears inadequate, by patient recall, and efforts to improve it are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Information bias in health research: definition, pitfalls, and adjustment methods
Althubaiti, A. (2016) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s104807 · Cited by 3,018
Jellinger, P. S., Handelsman, Y., Rosenblit, P. D., Bloomgarden, Z. T., Fonseca, V. A., Garber, A. J., Grunberger, G., Guerin, C. K., Bell, D. S. H., Mechanick, J. I., et al. (2017) · Endocrine Practice · doi:10.4158/ep171764.appgl · Cited by 1,094 · cited 1×
“This “shared decision-making” approach is strongly encouraged in the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines(14) and has been mentioned in several other contemporary guidelines, including the NLA Task Force on Lipid Safety–2014 update(15) and the American Associa…”
MethodSelf-citationCohen, J. D., Brinton, E. A., Ito, M. K., & Jacobson, T. A. (2012) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2012.03.003 · Cited by 486 · cited 6×
“05), and in which the primary reason for switching by current users was cost (32%) and the primary reason for discontinuation was side effects (62%).(8)”
BackgroundMethodResultInfluentialSelf-citationPredictors of Nonadherence to Statins: A Systematic Review and Meta-Analysis
Mann, D. M., Woodward, M., Muntner, P., Falzon, L., & Kronish, I. (2010) · Annals of Pharmacotherapy · doi:10.1345/aph.1p150 · Cited by 329
Cited by
Statin Toxicity: Mechanistic Insights and Clinical Implications
Ward, N. C., Watts, G. F., & Eckel, R. H. (2019) · Circulation Research · doi:10.1161/circresaha.118.312782 · Cited by 757
Prevalence of statin intolerance: a meta-analysis
Bytyçi, I., Penson, P. E., Mikhailidis, D. P., Wong, N. D., Hernandez, A. V., Sahebkar, A., Thompson, P. D., Mazidi, M., Rysz, J., Pella, D., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac015 · Cited by 481
Association Between Lipid Testing and Statin Adherence in the Veterans Affairs Health System
Jia, X., Al Rifai, M., Ramsey, D. J., Ahmed, S. T., Akeroyd, J. M., Nambi, V., Ballantyne, C. M., Petersen, L. A., Stone, N. J., & Virani, S. S. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.04.002 · Cited by 41
Rakhshanda, S., Briggs, N. E., Rhee, J., Rye, K.-A., Liaw, S.-T., & Jonnagaddala, J. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag175 · Cited by 6
Metadata
- Authors
- Brinton, E. A.
- Venue
- Clinical Cardiology
- Publisher
- Wiley
- Published
- 2018-06
- Volume
- 41
- Issue
- 6
- Pages
- 710-720
- ISSN
- 0160-9289 (ISSN-L)
- 1932-8737
- OpenAlex
- W2802528260
- Cited by
- 42
- References
- 4
- FWCI
- 5.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Understanding Patient Adherence and Concerns with STatins and MedicatION Discussions With Physicians (ACTION): A survey on the patient perspective of dialogue with healthcare providers regarding statin therapy. https://app.cochat.ai/papers/10.1002/clc.22975
- The paper
- Brinton, E. A. (2018). Understanding Patient Adherence and Concerns with STatins and MedicatION Discussions With Physicians (ACTION): A survey on the patient perspective of dialogue with healthcare providers regarding statin therapy. Clinical Cardiology. https://doi.org/10.1002/clc.22975
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.